Biomedical applications with emphasis on the design of smart materials, specifically
magnetic nanoparticles (MNPs) are considered to have technological benefits because they …

Gliomas are the most common primary brain tumors in adults. They arise in the glial tissue
and primarily occur in the brain. Low‐grade tumors of World Health Organization (WHO) …

Glioblastoma multiforme (GBM) is one of the most common, most formidable, and deadliest
malignant types of primary astrocytoma with a poor prognosis. At present, the standard of …

With the predicted rise in the incidence of cancer, there is an ever-growing need for new
cancer treatment strategies. Recently, magnetic nanoparticles have stood out as promising …

Traditional anti-cancer treatments are inefficient against glioblastoma, which remains one of
the deadliest and most aggressive cancers. Nano-drugs could help to improve this situation …

There are numerous investigated factors that limit brain cancer treatment efficacy such as
ability of prescribed therapy to cross the blood-brain barrier (BBB), tumor specific delivery of …

High-quality point-of-care is critical for timely decision of disease diagnosis and healthcare
management. In this regard, biosensors have revolutionized the field of rapid testing and …

The birth of RNAi technology has pioneered actionability at the molecular level. Compared
to DNA, RNA is less stable and therefore requires more demanding delivery vehicles. With …

Introduction Cancer has one of the highest mortality rates globally. The traditional therapies
used to treat cancer have harmful adverse effects. Considering these facts, researchers …

Rapid vascular growth, infiltrative cells and high tumor heterogenicity are some glioblastoma
multiforme (GBM) characteristics, making it the most lethal form of brain cancer. Low efficacy …